TXMD
TherapeuticsMD Inc
NASDAQ: TXMD · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.04
-3.32% today
Updated 2026-04-30
Market cap
$24.31M
P/E ratio
—
P/S ratio
8.04x
EPS (TTM)
$-0.06
Dividend yield
—
52W range
$1 – $3
Volume
0.0M
TherapeuticsMD Inc (TXMD) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-18.80%
Operating margin
-108.50%
ROE
-2.41%
ROA
-3.87%
Debt/equity
0.24x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $1.01M | $373015.00 | 79.57% | 48.63% | 37.11% |
| 2007 | — | $170542.00 | — | — | — |
| 2008 | — | $-395553.00 | — | — | — |
| 2009 | $10569.00 | $-1.65M | -308.29% | -15,570.87% | -15,654.66% |
| 2010 | $48217.00 | $-695375.00 | -49.18% | -970.53% | -1,442.18% |
| 2011 | $2.09M | $-12.91M | 54.64% | -259.90% | -618.40% |
| 2012 | $3.82M | $-35.12M | 64.69% | -422.95% | -919.86% |
| 2013 | $8.78M | $-28.42M | 77.67% | -294.09% | -323.84% |
| 2014 | $15.03M | $-54.22M | 75.56% | -359.65% | -360.82% |
| 2015 | $20.14M | $-85.08M | 77.63% | -422.93% | -422.37% |
| 2016 | $19.36M | $-89.88M | 78.38% | -466.27% | -464.32% |
| 2017 | $16.78M | $-76.93M | 84.28% | -462.69% | -458.50% |
| 2018 | $16.10M | $-132.62M | 83.00% | -808.85% | -823.74% |
| 2019 | $49.65M | $-176.15M | 87.24% | -304.56% | -354.79% |
| 2020 | $64.87M | $-183.52M | 75.37% | -239.77% | -282.90% |
| 2021 | $2.57M | $-172.41M | 45.51% | -3,092.77% | -6,700.93% |
| 2022 | $69.96M | $112.00M | 98.00% | 1.70% | 160.08% |
| 2023 | $1.30M | $-10.28M | 100.00% | -654.61% | -789.40% |
| 2024 | $1.76M | $-2.18M | 100.00% | -270.30% | -123.85% |
| 2025 | $3.02M | $-569000.00 | 60.52% | -139.44% | -18.83% |